by admin_63069 | Dec 30, 2019 | Articles of Interest, News You Can Use, Related Topics
Hormone therapies for advanced prostate cancer have greatly prolonged the lives of patients
by admin_63069 | Dec 18, 2019 | Articles of Interest, News You Can Use, Related Topics
Enzalutamide has previously been FDA-approved for treatment of metastatic castration-resistant prostate cancer (mCRCP) and non-metastatic castration-resistant prostate cancer (nmCRPC).
by admin_63069 | Dec 12, 2019 | Articles of Interest, News You Can Use, Related Topics
A new pilot study concludes that at-home urine tests could make prostate cancer diagnosis shorter, simpler, and possibly even more accurate.
by admin_63069 | Dec 9, 2019 | Articles of Interest, News You Can Use, Related Topics
After treatment, 65 percent of men in study had no signs of cancer after one year.
by admin_63069 | Dec 5, 2019 | Articles of Interest, News You Can Use, Related Topics, Uncategorized
By Radiological Society of North America, December 2, 2019
by admin_63069 | Dec 2, 2019 | Articles of Interest, News You Can Use, Related Topics
The treatment landscape for metastatic prostate cancer is shifting and expanding yet again, according to new findings from two large clinical trials presented at the American Society of Clinical Oncology.
